{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:06:40Z","timestamp":1785434800066,"version":"3.56.0"},"reference-count":51,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["AP26195973"],"award-info":[{"award-number":["AP26195973"]}]},{"award":["AP26195973"],"award-info":[{"award-number":["AP26195973"]}],"id":[{"id":"https:\/\/ror.org\/05tyne317","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer stem cells (CRC-SCs) contribute to treatment resistance, tumor recurrence and disease progression. Despite therapeutic advances, CRC-SCs frequently evade eradication and sustain tumor propagation. Although multiple molecular pathways have been implicated in this resistance, current preclinical evidence remains fragmented. This systematic review aims to synthesize preclinical evidence on the molecular mechanisms underlying CRC-SC resistance to modern anticancer therapies. A systematic search of PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials was conducted to identify peer-reviewed original studies published between 2015 and 2025. Eligible studies investigated molecular mechanisms of CRC-SC resistance to chemotherapy, targeted therapy, immunotherapy, and other therapeutic modalities. Risk of bias was assessed using QUIN for in vitro studies and SYRCLE for in vivo studies. A total of 26 studies met the inclusion criteria. Synthesis of findings showed that CRC-SC resistance is driven by interconnected mechanisms, including adaptive signaling pathways, epigenetic reprogramming, enhanced DNA damage response, and protective interactions within the tumor microenvironment. Several studies reported that combination treatments targeting these mechanisms attenuated stemness characteristics and restored therapeutic sensitivity. Overall, CRC-SC resistance arises from multiple intrinsic and extrinsic mechanisms, supporting further preclinical and translational evaluation of combination strategies.<\/jats:p>","DOI":"10.3390\/ijms27146285","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:49:36Z","timestamp":1784184576000},"page":"6285","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resistance of Colorectal Cancer Stem Cells to Modern Therapies: A Systematic Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8694-5226","authenticated-orcid":false,"given":"Sarzhan","family":"Rustemov","sequence":"first","affiliation":[{"name":"Department of Medicine, Nazarbayev University School of Medicine, Kerey-Zhanibek Khandar 5\/1, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8314-2797","authenticated-orcid":false,"given":"Alina","family":"Kuandyk","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Nazarbayev University School of Medicine, Kerey-Zhanibek Khandar 5\/1, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4633-0366","authenticated-orcid":false,"given":"Arailym","family":"Bertleuova","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Nazarbayev University School of Medicine, Kerey-Zhanibek Khandar 5\/1, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-0902","authenticated-orcid":false,"given":"Syed Hani","family":"Abidi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Nazarbayev University School of Medicine, Kerey-Zhanibek Khandar 5\/1, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis S.","family":"Bulanin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Nazarbayev University School of Medicine, Kerey-Zhanibek Khandar 5\/1, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2024","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wu, S., Zhang, Y., Lin, Z., and Wei, M. (2025). Global burden of colorectal cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-15138-0"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Haynes, J., and Manogaran, P. (2025). Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26051988"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"El-Tanani, M., Rabbani, S.A., Satyam, S.M., Rangraze, I.R., Wali, A.F., El-Tanani, Y., and Aljabali, A.A.A. (2025). Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies. Cancers, 17.","DOI":"10.3390\/cancers17030382"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3332\/ecancer.2025.2016","article-title":"Cancer stem cells and post-therapy tumour recurrence: A systematic review of mechanistic pathways and translational gaps","volume":"19","author":"Barjij","year":"2025","journal-title":"Ecancermedicalscience"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Duan, Y., Li, A., Miao, D., Tan, D., Wang, K., and Shi, J. (2025). Colorectal cancer stem cells crosstalk in tumor immune microenvironment and targeted therapeutic strategies. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1714954"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s12015-023-10529-x","article-title":"Cancer stem cells: An insight into the development of metastatic tumors and therapy resistance","volume":"19","author":"Nairuz","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103920","DOI":"10.1016\/j.critrevonc.2023.103920","article-title":"Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance","volume":"182","author":"Ebrahimi","year":"2023","journal-title":"Crit. Rev. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: Landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/jcrt.jcrt_388_24","article-title":"Epigenetics and cancer stem cells\u2014The world of cancer genesis: A review","volume":"21","author":"Tiwari","year":"2025","journal-title":"J. Cancer Res. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: Advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Roma-Rodrigues, C., Mendes, R., Baptista, P.V., and Fernandes, A.R. (2019). Targeting Tumor Microenvironment for Cancer Therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040840"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_14","first-page":"669","article-title":"FDA approves first CAR T therapy","volume":"16","author":"Mullard","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.prosdent.2022.05.019","article-title":"Development and validation of a risk-of-bias tool for assessing in vitro studies conducted in dentistry: The QUIN","volume":"131","author":"Sheth","year":"2024","journal-title":"J. Prosthet. Dent."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., de Vries, R.B.M., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s Risk of Bias Tool for Animal Studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_17","unstructured":"Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., Britten, N., Roen, K., and Duffy, S. (2006). Guidance on the Conduct of Narrative Synthesis in Systematic Reviews: A Product from the ESRC Methods Programme, University of Lancaster."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/abbs\/gmy018","article-title":"BRAF and EGFR inhibitors synergize to increase cytotoxic effects and decrease stem cell capacities in BRAF(V600E)-mutant colorectal cancer cells","volume":"50","author":"Wu","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"113535","DOI":"10.1016\/j.intimp.2024.113535","article-title":"Co-Colorectal cancer stem cells employ the FADS1\/DDA axis to evade NK cell-mediated immunosuppression after co-cultured with NK cells under hypoxia","volume":"143","author":"Geng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-023-03742-5","article-title":"Colorectal cancer tumor stem cells mediate bevacizumab resistance through the signal IL-22-STAT3 signaling pathway","volume":"13","author":"Qin","year":"2023","journal-title":"3 Biotech"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Guo, X., Liu, L., Zhang, Q., Yang, W., and Zhang, Y. (2020). E2F7 Transcriptionally Inhibits MicroRNA-199b Expression to Promote USP47, Thereby Enhancing Colon Cancer Tumor Stem Cell Activity and Promoting the Occurrence of Colon Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.565449"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Roy, S., Zhao, Y., Yuan, Y.C., and Goel, A. (2022). Metformin and ICG-001 Act Synergistically to Abrogate Cancer Stem Cells-Mediated Chemoresistance in Colorectal Cancer by Promoting Apoptosis and Autophagy. Cancers, 14.","DOI":"10.3390\/cancers14051281"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"109067","DOI":"10.1016\/j.jnutbio.2022.109067","article-title":"\u0394Np63\u03b1 mediates sulforaphane suppressed colorectal cancer stem cell properties through transcriptional regulation of Nanog\/Oct4\/Sox2","volume":"107","author":"Chen","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1010428317715155","DOI":"10.1177\/1010428317715155","article-title":"Upregulation of miR-199a\/b contributes to cisplatin resistance via Wnt\/\u03b2-catenin-ABCG2 signaling pathway in ALDHA1(+) colorectal cancer stem cells","volume":"39","author":"Chen","year":"2017","journal-title":"Tumor Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"109551","DOI":"10.1016\/j.jnutbio.2023.109551","article-title":"ZNF217-activated Notch signaling mediates sulforaphane-s uppressed stem cell properties in colorectal cancer","volume":"125","author":"Wang","year":"2024","journal-title":"J. Nutr. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25891","DOI":"10.18632\/oncotarget.25401","article-title":"Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin","volume":"9","author":"Huang","year":"2018","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acsptsci.1c00257","article-title":"Therapeutic Targeting of Cancer Stem Cells Prevents Resistance of Colorectal Cancer Cells to MEK Inhibition","volume":"5","author":"Lamichhane","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Su, Y., Choi, H.S., Choi, J.H., Kim, H.S., Jang, Y.S., and Seo, J.W. (2023). 7S,15R-Dihydroxy-16S,17S-epoxy-docosapentaenoic Acid Overcomes Chemoresistance of 5-Fluorouracil by Suppressing the Infiltration of Tumor-Associated Macrophages and Inhibiting the Activation of Cancer Stem Cells in a Colorectal Cancer Xenograft Model. Mar. Drugs, 21.","DOI":"10.3390\/md21020080"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s10620-025-09091-y","article-title":"The Combination of PF-543 and TRAIL Effectively Induces Apoptotic Cell Death and Inhibits Stem Cell-Like Properties Through the SPHK1\/S1PR1\/STAT3 Pathway in TRAIL-Resistant Colorectal Cancer Cells","volume":"70","author":"Kim","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5966\/sctm.2015-0214","article-title":"Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance","volume":"5","author":"Zeuner","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102664","DOI":"10.1016\/j.isci.2021.102664","article-title":"CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin","volume":"24","author":"Parrino","year":"2021","journal-title":"iScience"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gaggianesi, M., Mangiapane, L.R., Modica, C., Pantina, V.D., Porcelli, G., Di Franco, S., Lo Iacono, M., D\u2019Accardo, C., Verona, F., and Pillitteri, I. (2022). Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells. Cancers, 14.","DOI":"10.3390\/cancers14030673"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16902","DOI":"10.18632\/oncotarget.4642","article-title":"ErbB-3 activation by NRG-1\u03b2 sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)","volume":"6","author":"Prasetyanti","year":"2015","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41416-024-02649-z","article-title":"Inhibition of the AURKA\/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells","volume":"130","author":"Schlaepfer","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-025-02290-z","article-title":"Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3\/c-MYC axis","volume":"10","author":"Forte","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mattiello, L., Soliman Abdel Rehim, S., Musella, M., Sistigu, A., Guarracino, A., Vitale, S., Corradi, F., Galassi, C., Sperati, F., and Manic, G. (2021). The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition. Cancers, 13.","DOI":"10.3390\/cancers13081957"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Honma, S., Hisamori, S., Nishiuchi, A., Itatani, Y., Obama, K., Shimono, Y., and Sakai, Y. (2019). F-Box\/WD Repeat Domain-Containing 7 Induces Chemotherapy Resistance in Colorectal Cancer Stem Cells. Cancers, 11.","DOI":"10.3390\/cancers11050635"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s10020-024-01032-1","article-title":"Natural flavonoid Orientin restricts 5-Fluorouracil induced cancer stem cells mediated angiogenesis by regulating HIF1\u03b1 and VEGFA in colorectal cancer","volume":"31","author":"Ghosh","year":"2025","journal-title":"Mol. Med. Camb. Mass."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/14728222.2023.2266572","article-title":"Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells","volume":"27","author":"Paul","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/15384047.2016.1195045","article-title":"Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer","volume":"17","author":"Huynh","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"56558","DOI":"10.18632\/oncotarget.10646","article-title":"Pregnane X-receptor promotes stem cell-mediated colon cancer relapse","volume":"7","author":"Planque","year":"2016","journal-title":"Oncotarget"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s43018-024-00727-y","article-title":"The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors","volume":"5","author":"Bergin","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_43","first-page":"2337","article-title":"Preclinical investigation of ovatodiolide as a potential inhibitor of colon cancer stem cells via downregulating sphere-derived exosomal \u03b2-catenin\/STAT3\/miR-1246 cargoes","volume":"10","author":"Huang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yin, L., Zhou, S., Zhang, H., Shang, Y., Wu, S., and Jin, T. (2025). Cancer stem cells in personalized therapy: Mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1619597"},{"key":"ref_45","first-page":"1865","article-title":"Therapeutic Potential of Chemical Compounds in Targeting Cancer Stem Cells","volume":"Volume 1","author":"Raghav","year":"2022","journal-title":"Handbook of Oxidative Stress in Cancer: Therapeutic Aspects"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Huang, B., Yan, X., and Li, Y. (2021). Cancer Stem Cell for Tumor Therapy. Cancers, 13.","DOI":"10.3390\/cancers13194814"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1007\/s13277-016-4945-x","article-title":"Cancer stem cells, metabolism, and therapeutic significance","volume":"37","author":"Yang","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Aramini, B., Masciale, V., Grisendi, G., Bertolini, F., Maur, M., Guaitoli, G., Chrystel, I., Morandi, U., Stella, F., and Dominici, M. (2022). Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers, 14.","DOI":"10.3390\/cancers14040976"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Cho, Y., and Kim, Y.K. (2020). Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00764"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctrv.2018.07.004","article-title":"Cancer stem cell in breast cancer therapeutic resistance","volume":"69","author":"Bai","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"165339","DOI":"10.1016\/j.bbadis.2018.11.015","article-title":"Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance","volume":"1866","author":"Makena","year":"2020","journal-title":"Biochim. Biophys. Acta BBA-Mol. Basis Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6285\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:54:11Z","timestamp":1784184851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":51,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146285"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146285","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}